Read Chapter 6 of this book for FREE at the AIS Bookshelf! (Click on "Payer Strategies for Managing Specific Disease States.")
Highlights on this Page
Publication Details
- Pub Code: GSPRX5-11WEB
- Pages: 324
- ISBN: 1-933801-92-1
- Copyright 2010
3 Easy Ways to Order
- Secure Shopping Cart
- Print version only: Order now!
- Print & CD versions: Order now!
- Call 800-521-4323
- Print a form to fax or mail
Specialty Pharmacy: Stakeholders, Strategies and Markets 2011
A comprehensive picture of the rapidly changing biologicals, gene-based therapy and infusible and injectable drug markets. The book includes valuable data and statistics on the vendors serving this vital health care sector, the products involved, and the strategies employed by payers for managing and delivering these products to members.
Specialty Pharmacy: Stakeholders, Strategies and Markets 2011 features reliable and concise coverage of today’s hottest specialty pharma topics
The specialty pharmacy industry has grown and changed exponentially in recent years. Every health care insurer, provider and supplier will continue to be affected by changes in this category — especially now that there is an approval pathway for biosimilars.
Specialty Pharmacy: Stakeholders, Strategies and Markets is a unique resource that will help you stay on top of the rapidly changing biologicals, gene-based therapy and infusible and injectable drug markets. The 2011 edition features reliable and concise coverage of today’s hottest specialty pharma topics:
- The regulatory pathway for follow-on biologics — including estimates of the enormous savings potential, legal controversies and product development
- Developments in personalized medicine — including the impact of genetic testing on therapies, comparative effectiveness research, KRAS, and coverage and cost concerns
- Access and supply issues — such as the cerezyme supply shortage, patent issues and FDA approvals and expanded indications
- Health plan payer strategies for specific disease management states, including:
- Oncology
- Human Growth Hormone
- Multiple Sclerosis
- Hemophilia
- Rheumatoid Arthritis
- And more
- Major players in the specialty pharmacy arena — including a look at mergers and acquisitions, provider / payer partnerships, joint ventures, contracts and agreements, as well as the job market and the economic outlook for specialty pharmacy
Get the insight and guidance you need to navigate this big-dollar market. Order Specialty Pharmacy: Stakeholders, Strategies and Markets today!
Also Available on CD: For an additional $150, you can order the convenient CD version of Specialty Pharmacy: Stakeholders, Strategies and Markets along with the printed book. The CD contains all of the information in the print version and you’ll find what you need instantly with the user-friendly, searchable PDF format.
Table of Contents
Chapter 1: Evolution of the Specialty Pharmacy Market
- Defining the Specialty Pharmacy Industry
- Recent Specialty Pharmacy Mergers and Acquisitions
- Mergers and Acquisitions: 2008
- Mergers and Acquisitions: 2009
- Mergers and Acquisitions: 2010
- Economic Impact and Outlook for Specialty Pharmacy
- Specialty Pharmacy Job Market and Leadership Changes
- Specialty Pharmacy Evolutionary Timeline
Chapter 2: FDA Actions, Approvals and Expanded Indications
Chapter 3: Directory of Specialty Pharmacy and Specialty Infusion Providers and Related Services
Chapter 4: Contracting, Alliances and Partnerships
- Specialty Pharmacy Contracts and Agreements
- Partnerships, Alliances and Joint Ventures
Chapter 5: Strategies for Managing Therapies and Designing Benefits
- Benefit Design and Structure
- Employer Benefit-Design Strategies
- Managing Therapies
- ESAs
- Infusion
- Orphan Drugs
- New Products and Services
- Wellness
- REMS and Other Patient Safety Issues
Chapter 6: Payer Strategies for Managing Specific Disease States
- Hemophilia
- Hepatitis
- HIV/AIDS
- Human Growth Hormone
- Kidney Disease
- Multiple Sclerosis
- Ophthalmology
- Rheumatoid Arthritis
- Selected Major Conditions Targeted by Specialty Pharmacy Drugs
Chapter 7: Health Plan Strategies for Oncology Management
- Oral Oncology
- Cost and Reimbursement Issues
- Coverage Challenges
- Clinical Outcomes and Therapies
- Provider/Payer Partnerships
Chapter 8: Access and Supply Issues and Legal Battles
- Cerezyme Supply Shortage
- Coverage Policies
- Patent Issues
Chapter 9: Follow-On Biologics
- Establishing a Regulatory Pathway for Follow-On Biologics
- Approval Alternatives
- Product Development
- Savings Potential
- Controversies and Legal Battles
Chapter 10: Cost Trends and Strategies
- Specialty Pharmacy Drug Cost Trends
- Specialty Drug Spend
Chapter 11: Medicare Payment Methodologies and Reimbursement Strategies
- Medicare Part B Issues
- Reimbursement Challenges
- Coding for Avastin
- Medicare Competitive Acquisition Program (CAP)
Chapter 12: Personalized Medicine Developments and Oversight
- Legislation and Regulation of Genetic Testing
- Coverage and Cost Concerns
- Products and Services
- Impact of Genetic Testing on Therapies
- Genetic Testing for Cancer
- Comparative Effectiveness Research
- KRAS Testing
- Diagnostics
Written By
Specialty Pharmacy: Stakeholders, Strategies and Markets is written by the staff of Atlantic Information Services, Inc.
Written For
- Managed care payers
- Disease management companies
- Pharmaceutical retailers
- Physicians
- Pharmaceutical and biotech developers and manufacturers
- Pharmacy benefit managers
- Pharmaceutical distributors
- Home health providers
- Specialty outpatient clinics
AIS Guarantee
Order Specialty Pharmacy: Stakeholders, Strategies and Markets for a 30-day risk-free inspection and test for yourself the value of this highly practical resource. If within 30 days you're not interested in keeping it, just return it to AIS and we will send you a prompt, full refund or credit. For CD purchasers, refunds will not be made once the seal on the CD package has been broken. Please review your copy of the print version prior to breaking the seal.
Shipping Information
This item is shipped via UPS. Please give us your street address when you order (UPS does not deliver to PO boxes.) You should receive your order within 5-7 business days. Shipping cost is $12 per item.
Rush orders: Please call us at 800-521-4323 to place a rush order. We will overnight your order for an additional charge of $45, or you can give us your FedEx or UPS account number and we will charge the shipping to your account. Rush orders placed after 3:00pm EST will not be shipped out until the next business day.
Specialty Pharmacy: Stakeholders, Strategies and Markets 2011
MarketPlace Search
Renewal Center
Renew your subscriptions to AIS newsletter and looseleaf publications at the Renewal Center
Featured Pharmacy Benefit Management Products
All Featured Products
Books, Directories & Data
Looseleaf Guides
Atlantic Information Services, Inc. - 1100 17th Street NW, Suite 300, Washington, DC 20036 - 800-521-4323
Copyright © 2012 Atlantic Information Services, Inc. All Rights Reserved.
